#USA #New York #Class Action #Gross Law Firm #aTyr Pharma

aTyr Investors: Your Rights Are at Stake!

The Gross Law Firm has issued a crucial reminder for investors of aTyr Pharma, Inc. (NASDAQ: ATYR). If you purchased shares during the class period from January 16, 2025, to September 12, 2025, you may be eligible to participate in a pending class action lawsuit. The deadline for becoming a lead plaintiff is December 8, 2025.

What’s Happening?

This class action lawsuit arises from serious allegations against aTyr and its executives. The complaint suggests that they provided overly optimistic statements to investors while concealing critical information regarding the efficacy of their drug, Efzofitimod. Investors were misled about the drug's ability to allow complete tapering off of steroids. On September 15, 2025, following an investor call, it became public that the EFZO-FIT study failed to meet its primary endpoint, leading to a dramatic drop in aTyr's stock prices. In just one day, the share price plummeted by over 83% from $6.03 to $1.02.

Why Should You Act?

If you invested in aTyr during the specified period, it is vital to register as a shareholder now—even if you are not interested in being a lead plaintiff. By doing so, you will be enrolled in a portfolio monitoring program that will keep you updated on the case's status. Registering comes at no cost or obligation.

Importance of the Firm

The Gross Law Firm is highly regarded in the realm of class action lawsuits, dedicated to protecting investors' rights. This firm's goal is to ensure that companies adhere to ethical business practices and restore investor losses that stem from deceptive actions. With a mission of accountability, they are committed to providing justice to those who have experienced fraud in the market.

Next Steps

• - Register for the Class Action: To secure your participation, promptly register through the Gross Law Firm at this link.
• - Stay Informed: Once registered, you will receive critical updates about the lawsuit and any actions you may need to take as the case progresses.

Contact the Firm

For any questions or to learn more about your rights as a shareholder, please contact the Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Phone: (646) 453-8903
• - Email: [email protected]

In conclusion, if you are a shareholder of aTyr Pharma who suffered losses due to misleading information regarding the company's operations, you must take action now. This class action could be a significant opportunity for you to seek justice and recovery for your investments.

Ensure that your voice is heard and stand up for your rights as an investor. Don’t miss the deadline of December 8, 2025!